English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  The power of NGS technologies to delineate the genome organization in cancer: from mutations to structural variations and epigenetic alterations

Schweiger, M. R., Kerick, M., Timmermann, B., & Isau, M. (2011). The power of NGS technologies to delineate the genome organization in cancer: from mutations to structural variations and epigenetic alterations. Cancer Metastasis Reviews, 30(2), 199-210. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21267768 http://www.springerlink.com/content/7547m17657526w28/fulltext.pdf.

Item is

Basic

show hide
Item Permalink: http://hdl.handle.net/11858/00-001M-0000-0010-78FC-9 Version Permalink: http://hdl.handle.net/11858/00-001M-0000-0010-78FD-7
Genre: Journal Article

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Schweiger, M. R.1, Author              
Kerick, M.1, Author              
Timmermann, B.2, Author              
Isau, M.1, Author              
Affiliations:
1Cancer Genomics (Michal-Ruth Schweiger), Dept. of Vertebrate Genomics (Head: Hans Lehrach), Max Planck Institute for Molecular Genetics, Max Planck Society, ou_1479649              
2Sequencing, Max Planck Institute for Molecular Genetics, Max Planck Society, ou_1433559              

Content

show
hide
Free keywords: Base Sequence; Epigenomics/methods; Genetic Predisposition to Disease/genetics; Genome-Wide Association Study/*methods; Genomics/*methods; Humans; Mutation; Neoplasms/*genetics/pathology; Sequence Analysis, DNA/*methods; Translational Medical Research/methods/trends
 Abstract: The development of cancer is characterized by the joined occurrence of alterations on different levels--from single nucleotide changes via structural and copy number variations to epigenetic alterations. With the advent of advanced technologies such as next generation sequencing, we have now the tools in hands to put some light on complex processes and recognize systematic patterns that develop throughout cancer progression. The combination of single hypothesis-driven experiments with a system-wide genetic view enables us to prove so far not addressable questions such as the influence of DNA methylation on gene expression or the disruption of genome homeostasis by structural variations and miRNA expression patterns. Out of this enormous amount of information, specific biomarkers for cancer progression have been discovered, which pave the way for the development of new therapeutic strategies. Here, we will review the status quo of integrative cancer genomic approaches, give an overview over the power of next generation sequencing technologies in oncology, and outline future perspective. Both sides--clinical as well as basic research aspects--will be considered.

Details

show
hide
Language(s):
 Dates: 2011
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Cancer Metastasis Reviews
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 30 (2) Sequence Number: - Start / End Page: 199 - 210 Identifier: ISSN: 1573-7233 (Electronic) 0167-7659 (Linking)